Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution |
Is a |
Product containing dexamethasone sodium phosphate |
false |
Inferred relationship |
Some |
|
|
Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dexamethasone ophthalmic preparation |
false |
Inferred relationship |
Some |
|
|
Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dexamethasone sodium phosphate (substance) |
false |
Inferred relationship |
Some |
|
|
Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Some |
|
|
Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution |
Is a |
Product containing lidocaine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Lidocaine (substance) |
false |
Inferred relationship |
Some |
|
|
Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Adrenal hormone agent |
false |
Inferred relationship |
Some |
|
|
Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Glucocorticoid hormone |
false |
Inferred relationship |
Some |
|
|
Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution |
Has manufactured dose form |
injection |
false |
Inferred relationship |
Some |
|
|
Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution |
Is a |
Product containing dexamethasone in parenteral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution |
Is a |
Lidocaine-containing product in parenteral dose form |
false |
Inferred relationship |
Some |
|
|
Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dexamethasone (substance) |
false |
Inferred relationship |
Some |
|
|
Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Lidocaine hydrochloride |
false |
Inferred relationship |
Some |
|
|
Dexamethasone sodium phosphate + lidocaine hydrochloride 4mg/10mg per mL injection solution |
Has manufactured dose form |
Solution for injection |
false |
Inferred relationship |
Some |
|
|